Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exponent (EXPO) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Exponent (EXPO) over the last 16 years, with Q2 2025 value amounting to $4.2 million.

  • Exponent's Gains from Investment Securities fell 3869.92% to $4.2 million in Q2 2025 from the same period last year, while for Oct 2025 it was $5.7 million, marking a year-over-year decrease of 1614.13%. This contributed to the annual value of $379029.0 for FY2025, which is 1817.78% down from last year.
  • Exponent's Gains from Investment Securities amounted to $4.2 million in Q2 2025, which was down 3869.92% from $1.6 million recorded in Q1 2025.
  • Over the past 5 years, Exponent's Gains from Investment Securities peaked at $15.6 million during Q2 2021, and registered a low of $22000.0 during Q4 2023.
  • Moreover, its 5-year median value for Gains from Investment Securities was $5.5 million (2024), whereas its average is $5.8 million.
  • Over the last 5 years, Exponent's Gains from Investment Securities had its largest YoY gain of 708181.82% in 2025, and its largest YoY loss of 3869.92% in 2025.
  • Over the past 5 years, Exponent's Gains from Investment Securities (Quarter) stood at $32000.0 in 2021, then surged by 40225.0% to $12.9 million in 2022, then tumbled by 99.83% to $22000.0 in 2023, then surged by 54.55% to $34000.0 in 2024, then surged by 12152.94% to $4.2 million in 2025.
  • Its last three reported values are $4.2 million in Q2 2025, $1.6 million for Q1 2025, and $34000.0 during Q3 2024.